Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for BMRN

Stock Name	Biomarin Pharmaceutical Inc
Ticker	BMRN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US09061G1013
LEI	NSLL8ITTRR0J5HEMR848

Show aggregate BMRN holdings

News associated with BMRN

BioMarin Pharmaceutical (NASDAQ:BMRN) Coverage Initiated at HC Wainwright: HC Wainwright assumed coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) in a note issued to investors on Monday, MarketBeat.com reports. The firm set a “neutral” rating and a $60.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 7.74% from the stock’s previous […] - 2025-09-10 03:13:10
Predicting the Next Rule Breaker Buyout: In this Motley Fool Money podcast, Motley Fool analyst Karl Thiel and contributors Rick Munarriz and Jason Hall dig into four growth stocks ripe for the acquiring. There's also two sides to Tesla's changing AI story and a new kind of stock quote game. - 2025-08-19 01:08:00
9,709 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Atria Wealth Solutions Inc.: Atria Wealth Solutions Inc. bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 9,709 shares of the biotechnology company’s stock, valued at approximately $686,000. Several other hedge funds and other institutional investors also […] - 2025-08-13 04:49:08
Natixis Advisors LLC Grows Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Natixis Advisors LLC raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 68.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,226 shares of the biotechnology company’s stock after buying an additional 13,488 shares during the quarter. Natixis Advisors […] - 2025-08-08 07:20:44
Guggenheim Issues Positive Forecast for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price: BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its target price hoisted by investment analysts at Guggenheim from $101.00 to $106.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s price objective indicates a potential upside of 78.27% from the company’s current […] - 2025-08-08 04:26:58
BMRN Makes Bullish Cross Above Critical Moving Average: In trading on Tuesday, shares of BioMarin Pharmaceutical Inc (Symbol: BMRN) crossed above their 200 day moving average of $63.38, changing hands as high as $63.97 per share. BioMarin Pharmaceutical Inc shares are currently trading up about 5.7% on the day. The chart below show - 2025-08-05 12:47:37
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $93.74 Average Target Price from Analysts: Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-four research firms that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. […] - 2025-08-05 02:55:15
Biomarin Pharmaceutical Q2 25 Earnings Conference Call At 4:30 PM ET: (RTTNews) - Biomarin Pharmaceutical Inc. (BMRN) will host a conference call at 4:30 PM ET on August 4, 2025, to discuss Q2 25 earnings results. - 2025-08-04 08:30:49
Signaturefd LLC Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Signaturefd LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 19.1% during the 1st quarter, Holdings Channel reports. The institutional investor owned 2,191 shares of the biotechnology company’s stock after acquiring an additional 352 shares during the period. Signaturefd LLC’s holdings in BioMarin Pharmaceutical were worth $155,000 as of […] - 2025-07-21 05:36:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Nisa Investment Advisors LLC: Nisa Investment Advisors LLC lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.0% in the first quarter, Holdings Channel reports. The firm owned 4,572 shares of the biotechnology company’s stock after buying an additional 217 shares during the period. Nisa Investment Advisors LLC’s holdings in BioMarin Pharmaceutical were worth $323,000 as […] - 2025-07-17 06:25:00
Cerity Partners LLC Raises Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Cerity Partners LLC raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 203.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 84,832 shares of the biotechnology company’s stock after acquiring an additional 56,897 shares during the period. […] - 2025-07-17 05:51:03
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $113.00: BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective upped by JPMorgan Chase & Co. from $108.00 to $113.00 in a research report sent to investors on Monday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the biotechnology company’s stock. Other equities analysts have also issued research reports about the […] - 2025-07-17 04:48:52
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Xponance Inc.: Xponance Inc. raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 31,877 shares of the biotechnology company’s stock after buying an additional 202 shares during the quarter. Xponance Inc.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-07-15 07:02:50
D.A. Davidson & CO. Has $480,000 Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): D.A. Davidson & CO. lessened its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,788 shares of the biotechnology company’s stock after selling 746 shares during the quarter. D.A. Davidson […] - 2025-07-11 05:32:53
Brokerages Set BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) PT at $93.61: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. The average 1 […] - 2025-07-11 02:56:50
Principal Financial Group Inc. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Principal Financial Group Inc. lifted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 455,485 shares of the biotechnology company’s stock after purchasing an additional 1,549 shares during […] - 2025-07-08 06:26:49
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Sumitomo Mitsui Trust Group Inc.: Sumitomo Mitsui Trust Group Inc. lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 467,245 shares of the biotechnology company’s stock after selling 2,798 shares during the period. Sumitomo Mitsui Trust Group […] - 2025-07-03 06:13:02
Bessemer Group Inc. Has $327,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Bessemer Group Inc. reduced its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,618 shares of the biotechnology company’s stock after selling 683 shares during the quarter. Bessemer Group Inc.’s […] - 2025-07-03 05:00:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Robeco Institutional Asset Management B.V.: Robeco Institutional Asset Management B.V. boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 97,261 shares of the biotechnology company’s stock after purchasing an additional 10,687 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in BioMarin Pharmaceutical were […] - 2025-06-30 05:06:50
Kentucky Retirement Systems Insurance Trust Fund Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 5,490 shares of the biotechnology company’s stock, valued at approximately $388,000. A number of other institutional investors have also […] - 2025-06-26 05:04:54
Kentucky Retirement Systems Buys New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Kentucky Retirement Systems bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 12,890 shares of the biotechnology company’s stock, valued at approximately $911,000. Other hedge funds have also recently added to or reduced their stakes in the company. Farther Finance […] - 2025-06-25 05:40:49
Exchange Traded Concepts LLC Acquires 979 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Exchange Traded Concepts LLC boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,796 shares of the biotechnology company’s stock after acquiring an additional 979 shares during the quarter. Exchange Traded […] - 2025-06-19 04:58:54
Mn Services Vermogensbeheer B.V. Boosts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Mn Services Vermogensbeheer B.V. increased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.0% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 35,500 shares of the biotechnology company’s stock after buying an additional 3,800 shares during the period. Mn Services Vermogensbeheer […] - 2025-06-18 05:44:54
NorthCrest Asset Manangement LLC Acquires Shares of 4,885 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): NorthCrest Asset Manangement LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 4,885 shares of the biotechnology company’s stock, valued at approximately $345,000. Other hedge funds and […] - 2025-06-16 05:36:54
UMB Bank n.a. Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): UMB Bank n.a. grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 120.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,247 shares of the biotechnology company’s stock after acquiring an additional 1,228 shares during the period. UMB Bank […] - 2025-06-12 05:32:57
Gateway Investment Advisers LLC Cuts Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Gateway Investment Advisers LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 22.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,512 shares of the biotechnology company’s stock after selling 1,003 shares during the period. Gateway Investment Advisers LLC’s […] - 2025-06-10 05:26:59
Here Are All 6 Stocks I've Bought Through 5 Months of 2025: It's been a wild ride for the stock market through the first five months of 2025. As of mid-February, Wall Street's major stock indexes could do no wrong, with the benchmark S&P 500 vaulting to an all-time record-closing high. But over the next two months, tariff-related unce - 2025-06-05 04:06:00
Tidal Investments LLC Sells 17,428 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Tidal Investments LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 57.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,039 shares of the biotechnology company’s stock after selling 17,428 shares during the quarter. Tidal Investments LLC’s holdings in BioMarin […] - 2025-05-27 05:21:04
Quantinno Capital Management LP Purchases Shares of 5,848 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Quantinno Capital Management LP bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 5,848 shares of the biotechnology company’s stock, valued at approximately $384,000. A number […] - 2025-05-26 04:58:58
Analysts See 10% Upside For The Holdings of ILCB: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:58:34

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) BMRN holdings

Date	Number of BMRN Shares Held	Base Market Value of BMRN Shares	Local Market Value of BMRN Shares	Change in BMRN Shares Held	Change in BMRN Base Value	Current Price per BMRN Share Held	Previous Price per BMRN Share Held
2025-11-12 (Wednesday)	124,466	USD 6,885,459	USD 6,885,459	318	USD 66,009	USD 55.32	USD 54.93
2025-11-11 (Tuesday)	124,148	USD 6,819,450	USD 6,819,450	0	USD 280,575	USD 54.93	USD 52.67
2025-11-10 (Monday)	124,148	USD 6,538,875	USD 6,538,875	317	USD 166,532	USD 52.67	USD 51.46
2025-11-07 (Friday)	123,831	USD 6,372,343	USD 6,372,343	0	USD -47,056	USD 51.46	USD 51.84
2025-11-06 (Thursday)	123,831	USD 6,419,399	USD 6,419,399	317	USD -102,140	USD 51.84	USD 52.8
2025-11-05 (Wednesday)	123,514	USD 6,521,539	USD 6,521,539	0	USD 34,584	USD 52.8	USD 52.52
2025-11-04 (Tuesday)	123,514	USD 6,486,955	USD 6,486,955	318	USD -23,954	USD 52.52	USD 52.85
2025-11-03 (Monday)	123,196	USD 6,510,909	USD 6,510,909	0	USD -88,701	USD 52.85	USD 53.57
2025-10-31 (Friday)	123,196	USD 6,599,610	USD 6,599,610	0	USD 204,506	USD 53.57	USD 51.91
2025-10-30 (Thursday)	123,196	USD 6,395,104	USD 6,395,104	1,590	USD 88,617	USD 51.91	USD 51.86
2025-10-29 (Wednesday)	121,606	USD 6,306,487	USD 6,306,487	636	USD -164,198	USD 51.86	USD 53.49
2025-10-28 (Tuesday)	120,970	USD 6,470,685	USD 6,470,685	0	USD 99,195	USD 53.49	USD 52.67
2025-10-27 (Monday)	120,970	USD 6,371,490	USD 6,371,490	0	USD -218,956	USD 52.67	USD 54.48

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BMRN by Blackrock for IE00BDZVHG35

Show aggregate share trades of BMRN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 BUY 318 55.330 54.305 54.408 USD 17,302 61.48
2025-11-10 BUY 317 52.800 51.810 51.909 USD 16,455 61.56
2025-11-06 BUY 317 52.680 51.425 51.550 USD 16,342 61.67
2025-11-04 BUY 318 52.760 51.800 51.896 USD 16,503 61.77
2025-10-30 BUY 1,590 52.485 51.143 51.277 USD 81,531 61.91
2025-10-29 BUY 636 51.860 54.750 54.461 USD 34,637 61.97
2025-10-22 SELL -1,272 53.370 54.410 54.306 USD -69,077 62.20 Profit of 10,046 on sale
2025-10-20 BUY 636 53.070 53.550 53.502 USD 34,027 62.30
2025-10-17 BUY 1,589 53.290 53.490 53.470 USD 84,964 62.36
2025-10-15 BUY 2,536 53.090 53.760 53.693 USD 136,165 62.41
2025-10-03 BUY 2,212 55.430 56.000 55.943 USD 123,746 62.51
2025-10-02 BUY 316 55.570 55.990 55.948 USD 17,680 62.55
2025-09-30 BUY 632 54.160 54.420 54.394 USD 34,377 62.65
2025-09-26 BUY 632 53.850 53.970 53.958 USD 34,101 62.75
2025-09-25 BUY 632 52.620 54.500 54.312 USD 34,325 62.81
2025-09-18 BUY 330 55.140 55.220 55.212 USD 18,220 62.86
2025-09-17 BUY 993 54.370 55.180 55.099 USD 54,713 62.91
2025-09-11 SELL -331 55.910 55.950 55.946 USD -18,518 63.01 Profit of 2,340 on sale
2025-09-10 BUY 662 54.500 55.520 55.418 USD 36,687 63.07
2025-07-17 SELL -662 58.370 59.350 59.252 USD -39,225 63.22 Profit of 2,630 on sale
2025-07-16 BUY 1,126 58.390 58.580 58.561 USD 65,940 63.26
2025-07-11 SELL -2,624 58.100 58.500 58.460 USD -153,399 63.37 Profit of 12,877 on sale
2025-07-02 BUY 18,040 57.170 57.610 57.566 USD 1,038,491 63.51
2025-06-25 BUY 656 54.140 54.610 54.563 USD 35,793 63.75
2025-06-20 BUY 3,289 55.000 56.250 56.125 USD 184,595 63.95
2025-06-11 BUY 634 57.160 57.990 57.907 USD 36,713 64.37
2025-06-10 BUY 634 57.480 58.170 58.101 USD 36,836 64.42
2025-06-04 SELL -317 56.110 57.570 57.424 USD -18,203 64.68 Profit of 2,299 on sale
2025-04-23 BUY 317 61.940 63.390 63.245 USD 20,049 66.13
2025-04-10 SELL -2,536 56.320 58.330 58.129 USD -147,415 66.86 Profit of 22,153 on sale
2025-04-08 SELL -317 55.890 61.070 60.552 USD -19,195 67.08 Profit of 2,068 on sale
2025-04-07 SELL -317 59.160 60.610 60.465 USD -19,167 67.17 Profit of 2,125 on sale
2025-04-04 SELL -1,585 60.260 66.490 65.867 USD -104,399 67.25 Profit of 2,191 on sale
2025-04-01 BUY 2,736 67.940 70.630 70.361 USD 192,508 67.23
2025-03-31 SELL -936 70.690 71.280 71.221 USD -66,663 67.19 Loss of -3,777 on sale
2025-03-21 BUY 3,808 71.240 72.060 71.978 USD 274,092 66.83
2025-03-14 SELL -4,784 69.440 70.410 70.313 USD -336,377 66.53 Loss of -18,121 on sale
2025-03-07 SELL -598 72.230 73.510 73.382 USD -43,882 66.17 Loss of -4,311 on sale
2025-03-04 SELL -299 70.510 71.580 71.473 USD -21,370 65.94 Loss of -1,653 on sale
2025-02-25 BUY 598 71.170 71.580 71.539 USD 42,780 65.57
2025-02-19 SELL -299 65.610 65.690 65.682 USD -19,639 65.40 Loss of -84 on sale
2025-02-13 BUY 897 64.420 65.950 65.797 USD 59,020 65.45
2025-02-12 BUY 299 65.860 65.920 65.914 USD 19,708 65.44
2025-02-11 BUY 1,196 63.550 63.610 63.604 USD 76,070 65.48
2025-01-02 BUY 366 66.490 66.740 66.715 USD 24,418 66.35
2024-12-30 SELL -10,504 65.450 66.460 66.359 USD -697,035 66.37 Profit of 160 on sale
2024-11-18 SELL -4,890 61.930 63.520 63.361 USD -309,835 68.03 Profit of 22,825 on sale
2024-11-08 SELL -326 67.070 67.440 67.403 USD -21,973 68.23 Profit of 271 on sale
2024-10-21 SELL -326 70.280 70.810 70.757 USD -23,067 0.00 Loss of -23,067 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	BUY	318	55.330	54.305	54.408	USD 17,302	61.48
2025-11-10	BUY	317	52.800	51.810	51.909	USD 16,455	61.56
2025-11-06	BUY	317	52.680	51.425	51.550	USD 16,342	61.67
2025-11-04	BUY	318	52.760	51.800	51.896	USD 16,503	61.77
2025-10-30	BUY	1,590	52.485	51.143	51.277	USD 81,531	61.91
2025-10-29	BUY	636	51.860	54.750	54.461	USD 34,637	61.97
2025-10-22	SELL	-1,272	53.370	54.410	54.306	USD -69,077	62.20 Profit of 10,046 on sale
2025-10-20	BUY	636	53.070	53.550	53.502	USD 34,027	62.30
2025-10-17	BUY	1,589	53.290	53.490	53.470	USD 84,964	62.36
2025-10-15	BUY	2,536	53.090	53.760	53.693	USD 136,165	62.41
2025-10-03	BUY	2,212	55.430	56.000	55.943	USD 123,746	62.51
2025-10-02	BUY	316	55.570	55.990	55.948	USD 17,680	62.55
2025-09-30	BUY	632	54.160	54.420	54.394	USD 34,377	62.65
2025-09-26	BUY	632	53.850	53.970	53.958	USD 34,101	62.75
2025-09-25	BUY	632	52.620	54.500	54.312	USD 34,325	62.81
2025-09-18	BUY	330	55.140	55.220	55.212	USD 18,220	62.86
2025-09-17	BUY	993	54.370	55.180	55.099	USD 54,713	62.91
2025-09-11	SELL	-331	55.910	55.950	55.946	USD -18,518	63.01 Profit of 2,340 on sale
2025-09-10	BUY	662	54.500	55.520	55.418	USD 36,687	63.07
2025-07-17	SELL	-662	58.370	59.350	59.252	USD -39,225	63.22 Profit of 2,630 on sale
2025-07-16	BUY	1,126	58.390	58.580	58.561	USD 65,940	63.26
2025-07-11	SELL	-2,624	58.100	58.500	58.460	USD -153,399	63.37 Profit of 12,877 on sale
2025-07-02	BUY	18,040	57.170	57.610	57.566	USD 1,038,491	63.51
2025-06-25	BUY	656	54.140	54.610	54.563	USD 35,793	63.75
2025-06-20	BUY	3,289	55.000	56.250	56.125	USD 184,595	63.95
2025-06-11	BUY	634	57.160	57.990	57.907	USD 36,713	64.37
2025-06-10	BUY	634	57.480	58.170	58.101	USD 36,836	64.42
2025-06-04	SELL	-317	56.110	57.570	57.424	USD -18,203	64.68 Profit of 2,299 on sale
2025-04-23	BUY	317	61.940	63.390	63.245	USD 20,049	66.13
2025-04-10	SELL	-2,536	56.320	58.330	58.129	USD -147,415	66.86 Profit of 22,153 on sale
2025-04-08	SELL	-317	55.890	61.070	60.552	USD -19,195	67.08 Profit of 2,068 on sale
2025-04-07	SELL	-317	59.160	60.610	60.465	USD -19,167	67.17 Profit of 2,125 on sale
2025-04-04	SELL	-1,585	60.260	66.490	65.867	USD -104,399	67.25 Profit of 2,191 on sale
2025-04-01	BUY	2,736	67.940	70.630	70.361	USD 192,508	67.23
2025-03-31	SELL	-936	70.690	71.280	71.221	USD -66,663	67.19 Loss of -3,777 on sale
2025-03-21	BUY	3,808	71.240	72.060	71.978	USD 274,092	66.83
2025-03-14	SELL	-4,784	69.440	70.410	70.313	USD -336,377	66.53 Loss of -18,121 on sale
2025-03-07	SELL	-598	72.230	73.510	73.382	USD -43,882	66.17 Loss of -4,311 on sale
2025-03-04	SELL	-299	70.510	71.580	71.473	USD -21,370	65.94 Loss of -1,653 on sale
2025-02-25	BUY	598	71.170	71.580	71.539	USD 42,780	65.57
2025-02-19	SELL	-299	65.610	65.690	65.682	USD -19,639	65.40 Loss of -84 on sale
2025-02-13	BUY	897	64.420	65.950	65.797	USD 59,020	65.45
2025-02-12	BUY	299	65.860	65.920	65.914	USD 19,708	65.44
2025-02-11	BUY	1,196	63.550	63.610	63.604	USD 76,070	65.48
2025-01-02	BUY	366	66.490	66.740	66.715	USD 24,418	66.35
2024-12-30	SELL	-10,504	65.450	66.460	66.359	USD -697,035	66.37 Profit of 160 on sale
2024-11-18	SELL	-4,890	61.930	63.520	63.361	USD -309,835	68.03 Profit of 22,825 on sale
2024-11-08	SELL	-326	67.070	67.440	67.403	USD -21,973	68.23 Profit of 271 on sale
2024-10-21	SELL	-326	70.280	70.810	70.757	USD -23,067	0.00 Loss of -23,067 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BMRN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	410,026	8,500	779,513	52.6%
2025-09-18	309,934	9,272	546,271	56.7%
2025-09-17	792,001	76	1,198,919	66.1%
2025-09-16	481,505	0	1,174,969	41.0%
2025-09-15	537,109	68	901,192	59.6%
2025-09-12	559,519	41	804,638	69.5%
2025-09-11	479,992	858	740,032	64.9%
2025-09-10	670,394	301	865,419	77.5%
2025-09-09	347,787	0	583,412	59.6%
2025-09-08	440,427	0	726,535	60.6%
2025-09-05	291,870	0	466,536	62.6%
2025-09-04	516,779	0	829,878	62.3%
2025-09-03	280,802	0	490,768	57.2%
2025-09-02	312,757	0	686,202	45.6%
2025-08-29	214,126	13	370,043	57.9%
2025-08-28	251,916	7	439,795	57.3%
2025-08-27	370,349	6	578,905	64.0%
2025-08-26	289,675	233	549,904	52.7%
2025-08-25	355,827	100	585,453	60.8%
2025-08-22	357,184	16	556,528	64.2%
2025-08-21	352,501	1,525	524,293	67.2%
2025-08-20	339,777	74	602,589	56.4%
2025-08-19	220,437	0	499,041	44.2%
2025-08-18	330,939	435	644,696	51.3%
2025-08-15	498,822	0	931,913	53.5%
2025-08-14	241,436	0	529,668	45.6%
2025-08-13	719,992	350	1,132,112	63.6%
2025-08-12	217,242	4	606,989	35.8%
2025-08-11	336,985	0	722,604	46.6%
2025-08-08	574,538	39	1,320,708	43.5%
2025-08-07	387,504	31	837,240	46.3%
2025-08-06	571,718	43	896,314	63.8%
2025-08-05	1,685,687	12,503	3,542,200	47.6%
2025-08-04	1,579,757	0	3,686,257	42.9%
2025-08-01	716,526	0	2,200,777	32.6%
2025-07-31	549,459	38	925,084	59.4%
2025-07-30	718,573	10	1,234,755	58.2%
2025-07-29	226,725	75	481,375	47.1%
2025-07-28	243,626	5	412,929	59.0%
2025-07-25	247,295	86	445,587	55.5%
2025-07-24	380,699	137	586,872	64.9%
2025-07-23	251,713	0	450,219	55.9%
2025-07-22	387,886	114	638,283	60.8%
2025-07-21	228,375	6,803	346,208	66.0%
2025-07-18	292,003	100	575,028	50.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE